Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer
Phase 3
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2008-01-21
- Last Posted Date
- 2010-09-08
- Lead Sponsor
- Oakwood Laboratories, LLC
- Target Recruit Count
- 201
- Registration Number
- NCT00598312
- Locations
- 🇺🇸
Oakwood Laboratories, LLC, Oakwood Village, Ohio, United States
Clinical Trial for Prostate Cancer
Phase 3
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-01-27
- Last Posted Date
- 2008-01-28
- Lead Sponsor
- Oakwood Laboratories, LLC
- Registration Number
- NCT00076531
© Copyright 2025. All Rights Reserved by MedPath